Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN)

CUSIP: 59045L106

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
4,992,318
Total 13F shares
113,738,083
Share change
-343,102
Total reported value
$144,445,790
Put/Call ratio
4.6%
Price per share
$1.27
Number of holders
127
Value change
-$76,640,644
Number of buys
59
Number of sells
88

Quarterly Holders Quick Answers

What is CUSIP 59045L106?
CUSIP 59045L106 identifies MRSN - Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q3 2023

As of 30 Sep 2023, Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) was held by 127 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 113,738,083 shares. The largest 10 holders included EcoR1 Capital, LLC, VR Adviser, LLC, Bain Capital Life Sciences Investors, LLC, BlackRock Inc., VANGUARD GROUP INC, Bellevue Group AG, Balyasny Asset Management L.P., SILVERARC CAPITAL MANAGEMENT, LLC, Rock Springs Capital Management LP, and Affinity Asset Advisors, LLC. This page lists 127 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.